Expresson of the N-terminal Fragment Gene of Bactericidal/permeability Increasing Protein by E.coli and Its Initial Clinical Usage

Yu Zhou
2005-01-01
Abstract:Objective:To clone and express the gene of bactericidal/permeability-increasing protein and study its clinical usage.Methods:The cDNA of N-terminal fragment gene of bactericidal/permeability-increasing protein was amplified by RT-PCR using RNA isolated from human polymorphonuclear leukocytes cells (PMNL) and confirmed by sequencing.The PCR product was cloned into pBAD/Thio-TOPO vector,a expressing vector,resulting in a recombinant expressing plasmid.The plasmid was screened by restriction analysis and confirmed by sequencing,then introduced into E.coli TOP10.After induction with 2% L-Arabinose at 37℃,the recombinant protein was identified and analyzed by SDS-PAGE and Western blot.Then the recombinant protein was partially purified and its bioactivity was identified.Results:A 835 bp cDNA was amplified by RT-PCR and the sequence of the cDNA was identical with bactericidal/permeability-increasing protein cDNA reported.The cDNA of N-terminal fragment gene of bactericidal/permeability-increasing protein was cloned into expressing vector pBAD/Thio-TOPO.After induction,a protein with molecular weight of 39 kD was expressed as expected.The recombinant protein has the activity of immunity confirmed by Western blot and could suppress the growth of imipenem resistant P.aeruginosa.Conclusion:The cDNA of N-terminal fragment gene of bactericidal/permeability-increasing protein was successfully cloned and expressed.The prokaryotic expression plasmid pBAD-BPI was constructed successfully.The recombinant protein expressed has the activity of immunity and its bioactivity analysis showed that the protein inhibited the growth of imipenem resistant P.aeruginosa,thus provided the possibility for further research of BPI.
What problem does this paper attempt to address?